A drug traditionally used in Chinese folk medicine, qiliqiangxin, has proven effective in treating diseases of the cardiovascular system. This conclusion was reached by scientists who are members of the European Society of Cardiology, the results of their research presented at the annual ESC 2023 congress.
Ciliciangsin is an extract from 11 types of herbs, including yarrow roots, mulberry, ginseng, mint, and more. Preclinical studies have shown that siliciangsin has a beneficial effect in alleviating myocardial fibrosis and cardiac remodeling.
The study included more than 3,000 adult patients with heart failure who received baseline therapy. Patients were divided into groups: the first received the extract (four capsules three times a day), the second received a placebo in addition to the standard drugs for chronic heart failure. Participants were followed up to their first hospitalization for an average of one and a half years.
The results showed that the extract had a positive effect on the cardiovascular health of the participants, with fewer hospitalizations in the first group.
“To our knowledge, this was the first randomized, double-blind, controlled trial of a traditional Chinese medicine method for the treatment of chronic heart failure. Our results demonstrate an important clinical benefit of siliciangsin, supporting the use of the extract as adjunctive therapy in the treatment of heart failure,” concluded the authors.
ancient scientists establishedWhich diet reduces the risk of heart disease?